Skip to main content
. 2020 Feb 18;11:38. doi: 10.3389/fneur.2020.00038

Table 1.

Main clinical characteristics.

Initial herpetic meningo-encephalitis symptoms Delay between herpes and AIE Anti-NMDAr AIE onset First line immunotherapy (IVIG + corticosteroids) Second line immunotherapy (rituximab)
Case N°1 Akinetic mutism,
partial motor epilepsy
12 months Paranoid delirium, Capgras syndrome, anterograde amnesia Poor response Significant improvement
Case N°2 Superrefractory right temporal status epilepticus 7 months Paranoid delirium, Cotard syndrome, anterograde amnesia No response Significant improvement (back to previous state)